B7H3/IL-33信号在肺纤维化诱导的骨髓促纤维化改变中的作用
该研究探讨肺损伤/纤维化对骨髓的影响及其后续作用。将博来霉素处理供体小鼠的骨髓细胞移植给naive小鼠后,后者博来霉素诱导的肺纤维化显著加重,伴B7H3+细胞增多和Th2偏移;B7H3缺陷小鼠中该加重效应消失。特发性肺纤维化患者血浆及急性加重者BAL液中可溶性B7H3升高。结论提示肺纤维化通过B7H3相关机制改变骨髓单核细胞,进而增强后续纤维化。
要点
- 博来霉素预处理供体的骨髓移植可加重受者后续肺纤维化
- 该加重效应依赖B7H3,B7H3缺陷小鼠中不出现
- IPF患者血浆及AE-IPF者BAL液中可溶性B7H3升高
核心结论
- 肺纤维化可引起骨髓单核细胞扩增和激活,移植给naive受者后增强纤维化。
- B7H3在小鼠和人类肺纤维化病理生理中可能发挥新作用。
研究设计与样本
- 小鼠骨髓移植实验:对照或博来霉素处理供体骨髓移植给naive小鼠,评估博来霉素诱导肺纤维化。
- 在野生型和B7H3敲除小鼠中评估既往博来霉素处理对后续纤维化的影响。
- 分析特发性肺纤维化患者样本以评估临床相关性。
主要发现
- 接受博来霉素预处理供体骨髓的受者后续纤维化显著加重,B7H3+细胞增多且呈Th2偏移表型。
- 最小纤维化/非纤维化剂量博来霉素预处理也引起加重,但B7H3缺陷小鼠中未出现。
- 初始博来霉素预处理后接受naive骨髓细胞移植的小鼠未观察到加重。
- 可溶性B7H3体外刺激骨髓Ly6Chi单核细胞扩增,体内引起肺内类似扩增。
- IPF患者血浆及急性加重者BAL液中可溶性B7H3升高;ST2缺陷减弱博来霉素诱导的B7H3和IL-13上调。
临床怎么用
- 提示肺纤维化可远程改变骨髓造血,影响后续肺损伤反应,B7H3/IL-33轴可能为干预靶点。
- IPF患者血浆及AE-IPF者BAL液中可溶性B7H3升高,提示其作为生物标志物的潜在价值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rationale: The impact of lung insult on the bone marrow (BM) and subsequent disease is unknown.Objectives: To study alterations in the BM in response to lung injury/fibrosis and examine their impact on subsequent lung insult.Methods: BM cells from control or bleomycin-treated donor mice were transplanted into naive mice, which were subsequently evaluated for bleomycin-induced pulmonary fibrosis. In addition, the effect of prior bleomycin treatment on subsequent fibrosis was examined in wild-type and B7H3-knockout mice. Samples from patients with idiopathic pulmonary fibrosis were analyzed for potential clinical relevance of the findings.Measurements and Main Results: Recipient mice transplanted with BM from bleomycin-pretreated donors showed significant exacerbation of subsequent fibrosis with increased B7H3+ cell numbers and a T-helper cell type 2-skewed phenotype. Pretreatment with a minimally fibrogenic/nonfibrogenic dose of bleomycin also caused exacerbation, but not in B7H3-deficient mice. Exacerbation was not observed if the mice received naive BM cell transplant after the initial bleomycin pretreatment. Soluble B7H3 stimulated BM Ly6Chi monocytic cell expansion in vitro and caused similar expansion in the lung in vivo. Notably, soluble B7H3 was elevated in plasma of patients with idiopathic pulmonary fibrosis and in BAL fluid in those with acute exacerbation. Finally, ST2 deficiency diminished the bleomycin-induced B7H3 and IL-13 upregulation, suggesting a role for type 2 innate lymphoid cells.Conclusions: Pulmonary fibrosis caused significant alterations in BM with expansion and activation of monocytic cells, which enhanced fibrosis when transplanted to naive recipients with potential mediation by a novel role for B7H3 in the pathophysiology of pulmonary fibrosis in both mice and humans.
引用
- Nakashima T, Liu T, Hu B, et al. Role of B7H3/IL-33 Signaling in Pulmonary Fibrosis-induced Profibrogenic Alterations in Bone Marrow. Am J Respir Crit Care Med. 2019. PMID: 31106564. doi:10.1164/rccm.201808-1560OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。